Micafungin sodium and Ranitidine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Micafungin sodium (micafungin sodium) and Ranitidine (ranitidine). Common drug interactions include aplastic anaemia among females and aplastic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Micafungin sodium and Ranitidine. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Micafungin sodium?

Micafungin sodium has active ingredients of micafungin sodium. eHealthMe is studying from 1,787 Micafungin sodium users. Check the latest studies of Micafungin sodium.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,475 Ranitidine users. Check the latest studies of Ranitidine.

On Jul, 19, 2026

16 people who take Micafungin sodium and Ranitidine together, and have interactions are studied.

Micafungin sodium and Ranitidine drug interactions.

What are the common drug interactions of Micafungin Sodium and Ranitidine, by gender? *:

female:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Nausea (feeling of having an urge to vomit)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting

male:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Pneumonia
Dysphagia (a condition in which swallowing is difficult or painful)
Obstruction gastric (obstruction in stomach)
Fatigue (feeling of tiredness)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
Mucosal inflammation (infection of mucous membrane)
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the common drug interactions of Micafungin Sodium and Ranitidine, by age (0-1 to 60+)? *:

0-1:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)

2-9:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Pyrexia (fever)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)

10-19:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Acute febrile neutrophilic dermatosis (skin disease characterized by the sudden onset of fever, leukocytosis, and tender)
Fatigue (feeling of tiredness)
Hypogonadism (reduction or absence of hormone secretion or other physiological activity of the gonads (testes or ovaries))
Mucosal inflammation (infection of mucous membrane)
Nausea (feeling of having an urge to vomit)
Odynophagia (painful swallowing, in the mouth (oropharynx) or oesophagus)
Pancreatitis acute (sudden inflammation of pancreas)
Vomiting

20-29:

n/a

30-39:

Acute graft versus host disease in intestine (acute complication in intestine following an allogeneic tissue/blood transplant)
Acute graft versus host disease in liver (acute complication in liver following an allogeneic tissue/blood transplant)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
Thrombotic microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury)

40-49:

n/a

50-59:

Dysphagia (a condition in which swallowing is difficult or painful)
Obstruction gastric (obstruction in stomach)

60+:

Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Sepsis (a severe blood infection that can lead to organ failure and death)

What are the existing conditions these people have? *

Constipation: 3 people, 18.75%
Bone Marrow Conditioning Regimen: 3 people, 18.75%
Fever: 3 people, 18.75%
Pain: 3 people, 18.75%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 12.50%
Infection: 2 people, 12.50%
Insomnia (sleeplessness): 2 people, 12.50%
Lymphoma (cancer that begins in immune system cells): 2 people, 12.50%
Tumor Lysis Syndrome: 2 people, 12.50%
Acute Myeloid Leukaemia Recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Micafungin sodium and Ranitidine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously